The primary outcome , the placebo-corrected mean ratio of the UACR at day @ relative to baseline , was reduced in the finerenone @ - , @ - , @ - , and @-mg/d groups ( for @ mg/d , @ -LSB- @ % CI , @-@ @ ; P = @ -RSB- ; for @ mg/d , @ -LSB- @ % CI , @-@ @ ; P = @ -RSB- ; for @ mg/d , @ -LSB- @ % CI , @-@ @ ; P < @ -RSB- ; for @ mg/d , @ -LSB- @ % CI , @-@ @ ; P < @ -RSB- ) .